Stocktoria
PharmaCyte Biotech, Inc. PMCB
Nasdaq · XNAS · stock · Biological Products, (No Diagnostic Substances) · website · IPO 2003-09-11
PharmaCyte Biotech, Inc. insider transactions (Form 4)
| Insider | Role | Date | Action | Shares | Price |
|---|---|---|---|---|---|
| Silverman Joshua | CEO and President | 2026-01-07 | Buy | 40,000 | $0.83 |
| SCHECHTER JONATHAN | director | 2026-01-07 | Buy | 20,000 | $0.84 |
| Silverman Joshua | CEO and President | 2026-01-06 | Buy | 30,000 | $0.79 |
| SCHECHTER JONATHAN | director | 2026-01-06 | Buy | 20,000 | $0.79 |
| SCHECHTER JONATHAN | director | 2026-01-05 | Buy | 20,000 | $0.78 |
| Silverman Joshua | CEO and President | 2026-01-05 | Buy | 30,000 | $0.78 |
| Silverman Joshua | CEO and President | 2025-12-12 | Tax withheld | 258,750 | $1.02 |
| WEINSTEIN ROBERT | director | 2025-12-12 | Grant | 75,000 | — |
Source: SEC EDGAR filings · CIK 0001157075 · as of 2025-04-30. Facts from filings plus Stocktoria's own computed scores — not investment advice.